Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.05B
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
3.17M
-
Shares change
-
+419K
-
Total reported value, excl. options
-
$5.42M
-
Value change
-
+$729K
-
Number of buys
-
9
-
Number of sells
-
-4
-
Price
-
$1.71
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q2 2020
15 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q2 2020.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.17M shares
of 2.05B outstanding shares and own 0.15% of the company stock.
Largest 10 shareholders include BVF INC/IL (1.69M shares), MORGAN STANLEY (565K shares), Senvest Management, LLC (451K shares), RENAISSANCE TECHNOLOGIES LLC (157K shares), Psagot Investment House Ltd. (117K shares), ORBIMED ADVISORS LLC (69.2K shares), GOLDMAN SACHS GROUP INC (37.9K shares), LPL Financial LLC (19.9K shares), ACADIAN ASSET MANAGEMENT LLC (19K shares), and Cutter & CO Brokerage, Inc. (17.8K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.